For a comprehensive real-world analysis considering both tumor and tumor micro-environment (TME) immune cells, we applied the frequently used Combined Positivity Score (CPS), covering all PD-L1-expressing cells (tumor cells, macrophages, and lymphocytes, among others). The gene discussed is CD274; the disease is neoplasm.